FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study

scientific article published in January 2007

FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/145749690709600305
P698PubMed publication ID17966746

P50authorMichael SørensenQ40878926
Frank Viborg MortensenQ43108632
Morten HøyerQ61142632
Hendrik VilstrupQ90294570
Susanne KeidingQ91204390
P2093author name stringLiver Tumour Board at Aarhus University Hospital
P2860cites workSurgical resection of hepatic metastases from colorectal cancer: a systematic review of published studiesQ24651894
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database studyQ28354043
Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.Q34399663
FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.Q34433747
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastasesQ34471196
PET and PET-CT for evaluation of colorectal carcinomaQ35808245
Making unresectable hepatic colorectal metastases resectable--does it work?Q36363334
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumorsQ44759091
FDG-PET for the pre-operative evaluation of colorectal liver metastasesQ44803642
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.Q44936038
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).Q45023757
The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastasesQ46662727
P433issue3
P921main subjectFluorodeoxyglucose Positron Emission TomographyQ130273243
P304page(s)209-213
P577publication date2007-01-01
P1433published inScandinavian Journal of SurgeryQ15720850
P1476titleFDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study
P478volume96

Reverse relations

cites work (P2860)
Q45922514Additional value of FDG-PET/CT in management of "solitary" liver metastases: preliminary results of a prospective multicenter study.
Q38260616Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review
Q52962069Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
Q37449388Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases
Q34494815Positron emission tomography for benign and malignant disease.
Q33704285Relationship Between Dual-Time Point FDG PET and Immunohistochemical Parameters in Preoperative Colorectal Cancer: Preliminary Study

Search more.